ArticleCancers2019

Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin.

Alexandre de Nonneville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.